iKang Healthcare Group (KANG) and Concord Medical Services (CCM) Financial Analysis

iKang Healthcare Group (NASDAQ: KANG) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends.

Analyst Recommendations

How to Become a New Pot Stock Millionaire

This is a breakdown of recent recommendations for iKang Healthcare Group and Concord Medical Services, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iKang Healthcare Group 0 0 0 0 N/A
Concord Medical Services 0 0 0 0 N/A

Insider & Institutional Ownership

33.5% of iKang Healthcare Group shares are held by institutional investors. Comparatively, 1.8% of Concord Medical Services shares are held by institutional investors. 30.2% of iKang Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares iKang Healthcare Group and Concord Medical Services’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
iKang Healthcare Group $435.71 million 3.20 -$11.25 million N/A N/A
Concord Medical Services $65.54 million 2.00 -$37.71 million ($0.87) -3.47

iKang Healthcare Group has higher revenue and earnings than Concord Medical Services.

Profitability

This table compares iKang Healthcare Group and Concord Medical Services’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
iKang Healthcare Group 3.16% 4.97% 2.30%
Concord Medical Services N/A N/A N/A

Risk & Volatility

iKang Healthcare Group has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500.

Summary

iKang Healthcare Group beats Concord Medical Services on 8 of the 9 factors compared between the two stocks.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc. provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services. The Company, through its integrated service platform, offers healthcare management solutions, including medical examinations, which cover basic examination items, such as internal, gynecology, ophthalmology, dental and X-ray, and value-added services at selected medical centers, including disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening and functional medicine testing; dental care, including oral health, pediatric dentistry and cosmetic dentistry; outpatient services, such as acupuncture, obstetrics, gynecology and minor surgery, and on-site healthcare management or clinics at certain locations.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services. It also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions, as well as CT scanners and ECT scanners for diagnostic imaging. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as consulting services; sells medical equipment; and researches and develops medical technology. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2016, it operated a network of 95 cooperative centers based in 57 hospitals in 49 cities across 19 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply